Introduction
Essential hypertension is a multifactorial and polygenic disorder, and several genes are thought to play a role in its pathogenesis. The renin-angiotensin system (RAS) is one of the important factors that regulates the blood pressure, as well as fluid and electrolyte balance, and may have an important role in the pathogenesis of hypertension (Malik et al., 1997) .
The angiotensin converting enzyme (ACE) I/D polymorphism, identified in 1990 by Rigat et al. , is partially associated with the plasma ACE level. Although the ACE DD genotype increases the plasma ACE concentration and the risk for numerous cardiovascular-renal diseased states, such as myocardial infarction (Cambien et al., 1992) , cardiomyopathy (Marian et al., 1993) , IgA nephropathy (Harden et al., 1995) , and diabetic nephropathy (Marre et al., 1994) , the findings from case-control studies have not been consistently positive.
Several molecular variants of the angiotensinogen (AGN) gene have been detected. A polymorphism in exon 2, in which methionine at position 235 is replaced by threonine (M235T variant) has been associated with essential hypertension in both whites (Jeunemaitre et al., 1992) and Japanese (Hata et al., 1994 , Nishiuma et al., 1995 . However, other studies have failed to show an association of the M235T variant with essential hypertension in whites at British (Caulfield et al., 1994) , Australian (Bennett et al., 1993) and Japanese (Morise et al., 1995) population. Another polymorphism in exon 2, in which threonine at position 174 is replaced by methionine (T174M variant), has also been associated with essential hypertension in whites (Jeunemaitre et al., 1992) and Japanese (Morise et al., 1995) . However, Caulfield et al. (Caulfield et al., 1994) failed to detect an associAngiotensin converting enzym e I/D, angiotensinogen T174M-M235T and angiotensin II type 1 receptor A1166C gene polym orphism s in Turkish hypertensive patients ation of the T174M variant with essential hypertension in whites in the British population. Thus the association between angiotensinogen gene polymorphisms and essential hypertension remains controversial.
Of the two subtypes of angiotensin II receptors (ATR1 and ATR2), ATR1 appears to mediate the physiologic effects of angiotensin II important for blood pressure regulation, and thus polymorphism in this gene has the potential to affect blood pressure regulation. As in studies of other renin-angiotensin system genes, association studies of ATR1 polymorphism present a mixed picture, including significant associations (Bonnardeaux et al., 1994; Wang et al., 1997; Kainulainen et al., 1999) , negative findings (Schmidt et al., 1997) , and inconclusive results (Szombathy et al., 1998; Tiret et al., 1998) .
Interethnic differences in vascular disease demography indicate the need to examine the relationship between three RAS gene polymorphisms and hypertension in Turkey. Investigation of this important ethnic group may help to establish a genetic basis to account for the observed ethnic differences in the incidence and pathogenesis of vascular disease. We aimed to investigate the relation between polymorphism of RAS genes and hypertension in Turkish population.
M aterials and M ethods Subjects
The hypertensive group consisted of 109 subjects from the hypertension outpatient clinic of Marmara University Hospital. Hypertension was defined as systolic blood pressure (SBP) 140 mmHg or diastolic blood pressure (DBP) 90 mmHg or those currently receiving one or more antihypertensive drugs. Secondary forms of hypertension were excluded by clinical and laboratory examination. The 86 normotensive controls had negative family history off hypertension and SBP 140 mmHg and DBP 90 mmHg on three occasions spanning two months. Demographic and blood chemistry data were obtained from questionaries and laboratory examinations.
G enotyping protocols
Genomic DNA was extracted from peripheral blood leukocytes usind salting out method as described by Miller et al. (Miller et al., 1988) . Polymerase chain reaction based protocols were used to identify the ACE gene I/D (Rigat et al., 1992; Lindpaintner et al., 1995) , AGN M235T (Russ et al., 1993) , AGN T174M (Caulfield et al., 1994) and ATR1 A1166C (Bonnardeaux et al., 1994) 
R esults
The clinical and biochemical parameters of the controls and hypertensive subjects are shown in Table  1 . Between the two groups, a statistically significant difference was observed in the BMI, BP level and LDL-Cholesterol. Table 2 show the distribution of the genotype and allele frequencies of ACE, AGN and ATR1 gene polymorphisms of controls and hypertensive subjects among males and females. Hovewer, pooling ACE DD and ID individidual and compared II genotypic group, the frequencies of person that carry ACE D allel (DD+ID) was significantly higher in hypertensives groups (99.1%) than controls (80%) (χ 2 :20.66; P = 0.000). When the sexes were examined separately, this difference was higly significant in women (P = 0.010, Fisher exact test). AGN M235T TT genotypes was found significantly higher in hypertensive than control groups (20% vs 2.7%; (χ 2 :11.52, P=0.001), in male subjects this ratio was 22.6% in hypertensive and 2.3% in controls (P = 0.007, Fisher exact test); in female subjects 18.8% vs 3.3% (P = 0.035, Fisher exact test) The frequency of AGN 174 M allele was slightly increased in hypertensive patients as compared to the control subjects. The estimated relative risk of hypertension with carrier M allele as compared with control subjects were 1.992 (OR: 1.992, 95% CI 0.812-4.883). Frequency of ATR1 C allele carriers (AC+CC genotypes) was found higher hypertensives than controls (39.4% vs 25.9%)(P = 0.054). In males this ratio was 40% in hypertensives and 22.9% in controls (OR:2.242; 95% CI: 0.831-6.055) and in women (39.2%) versus control (30.3%) (OR 1.482; 95% CI: 0.617-3.563).
D iscussion
In this study, we aimed to investigate the association between ACE (I/D) and angiotensinogene (T174M/M-235T) and ATR1 A1166C gene polymorphisms in Turkish hypertensive patients.
The frequency of the ACE deletion (D) allele has been found to be higher in hypertensive patients than control subjects (χ 2 : 20.66, P = 0.000). When we compared ACE allele among the controls in the present study and with that in populations, reported by Abbud (Abbud et al., 1998) , Bedir (Bedir et al., 1999) and O'Donnel (O'Donnell et al., 1998) , it was found to be Evidences of genetic linkage between the angiotensinogen gene and essential hypertension has been described; both M235T and T174M variants were strongly associated with high blood pressure (Jeunemaitre et al., 1992) . However, the frequency of the T allele of M235T polymorphism markedly varies among ethnic groups. The frequency of the T allele varies between 0.35 and 0.49 in whites (Jeunemaitre et al., 1992; Caulfield et al., 1994) and between 0.60 and 0.79 in Japanese (Morise et al., 1995; Nishiuma et al., 1995) , thus the frequency in the Japanese population is 1.2 to 2.3 times that in the white population. In our study, the frequency of the T allele was 0.34 in the control subjects, a value similar to those reported for whites by Jeunemaitre et al. (Jeunemaitre et al., 1992) (0.35) and Caulfield et al. (Caulfield et al., 1994) (0.49) but significantly different than those obtained for black and Japanese populations by Rotimi et al. (Rotimi et al., 1994) (0.95), Nishiuma et al. (Nishiuma et al., 1995) (0.62) and Ishigami et al. (Ishigami et al., 1994) (0.65), Hata et al. (Hata et al., 1994) (0.75) and Morise et al. (Morise et al., 1995) (0.79) .
In this study we observed a higher frequency of AGT 174 M allele in the hypertensive group (8.76%) than in control subjects (4.81%) in Turkish population. The estimated relative risk of hypertension with carrier M allele as compared with control subjects was 1.992 with 95% CI 0.812-4.883. We found T174M genotype frequencies similar to other populations and found no homozigous T174M MM genotype like Forrester et al. (Forrester et al., 1996) , and Rotimi et al. (Rotimi et al., 1994) .
The ATR1 A1166C polymorphism is located at the 5' end of the 3' untranslated region of the gene (Bonnardeaux et al., 1994) . It has been shown that the frequency of the ATR1 C allele is increased in patients with severe hypertension (Bonnardeaux et al., 1994) . In our study, there was a relationship observed between the ATR1 A1166C polymorphism and hypertension.
In conclusion, we found association between the ACE, AGN and ATR1 gene polymorphism and hypertension in Turkish population, in agreement with recent reports performed in different white populations. Further candidate gene analysis can be expected to elucidate the genetic background of essential hypertension in future.
